Trauma surgeons in Ukraine working theaters saved lives and limbs because of the modern lab-grown blood vessels from US biotech, Humacyte.
Humacyte is pioneering a platform that allows the investigation, improvement, and manufacture of bioengineered human tissues and organs which can be designed to be universally implantable, off-the-shelf, and regenerative, with the purpose of treating all kinds of illnesses, accidents, and power situations.
This week I had the prospect to talk to Humacyte founder, President and Chief Government Laura Niklason in regards to the firm she has constructed, the science she is driving ahead, and the real-world purposes for Humacyte’s lab-grown blood vessels in among the most devastating and harmful conflicts.
1:00 Introducing Laura Niklason
4:50 Humacyte and its mission
6:27 Aggressive panorama
7:45 Partnering for scale
9:49 Methods to develop blood vessels within the lab
11:47 Implanting the vessels
13:32 Human vessels vs artificial vessels
15:10 The manufacturing course of
16:23 Overcoming skepticism, demonstrating worth
19:01 Navigating the regulatory approval course of
21:17 The position of the Division of Protection in modern biotech
22:30 Utilizing Humacyte vessels within the discipline
23:20 Humacyte vessels within the Ukraine Struggle
28:22 Classes from the Ukraine Struggle
30:09 Targets for the approaching years
33:35 Scaling manufacturing
Fascinated by being a sponsor of an episode of our podcast? Uncover how one can become involved right here!
Keep up to date by subscribing to our e-newsletter
To dive deeper into the subject:
Introducing Laura Niklason
Methods to develop blood vessels within the lab
Human vessels vs artificial vessels
The manufacturing course of
Overcoming skepticism, demonstrating worth
Navigating the regulatory approval course of
The position of the Division of Protection in modern biotech
Utilizing Humacyte vessels within the discipline
Humacyte vessels within the Ukraine Struggle
Classes from the Ukraine Struggle
Targets for the approaching years
